Transgene S.A.
TRGNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $76 | $155 | $150 | $149 |
| - Cash | $17 | $17 | $15 | $16 |
| + Debt | $31 | $10 | $0 | $1 |
| Enterprise Value | $91 | $149 | $134 | $134 |
| Revenue | $5 | $0 | $0 | $3 |
| % Growth | 1,512.3% | 1,134.8% | -99.3% | – |
| Gross Profit | -$13 | $16 | -$15 | -$11 |
| % Margin | -291.1% | 5,530.6% | -66,956.5% | -346.9% |
| EBITDA | -$16 | -$8 | -$19 | -$13 |
| % Margin | -358.4% | -2,854.9% | -80,626.1% | -429.2% |
| Net Income | -$19 | -$17 | -$16 | -$6 |
| % Margin | -421.4% | -6,157% | -71,673.9% | -204.8% |
| EPS Diluted | -0.15 | -0.18 | -0.16 | -0.063 |
| % Growth | 16.7% | -12.5% | -152.4% | – |
| Operating Cash Flow | -$18 | -$5 | -$18 | -$17 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$18 | -$6 | -$20 | -$18 |